Octavio Marquez - Feb 14, 2023 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
President and CEO, Director
Signature
Jonathan B. Leiken, Attorney-in-fact for Octavio Marquez
Stock symbol
DBD
Transactions as of
Feb 14, 2023
Transactions value $
$20,440
Form type
4
Date filed
2/14/2023, 03:58 PM
Previous filing
Feb 13, 2023
Next filing
Mar 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Purchase $20.4K +7K +1.99% $2.92* 358K Feb 14, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Option 15.9K Feb 14, 2023 Common Shares 15.9K $34.13 Direct F2
holding DBD Non-Qualified Stock Option 22.7K Feb 14, 2023 Common Shares 22.7K $32.33 Direct F2
holding DBD Non-Qualified Stock Option 16.4K Feb 14, 2023 Common Shares 16.4K $27.39 Direct F2
holding DBD Non-Qualified Stock Option 38K Feb 14, 2023 Common Shares 38K $26.60 Direct F3
holding DBD Non-Qualified Stock Option 19.8K Feb 14, 2023 Common Shares 19.8K $18.75 Direct F3
holding DBD Non-Qualified Stock Option 33.8K Feb 14, 2023 Common Shares 33.8K $4.08 Direct F3
holding DBD Non-Qualified Stock Option 9.33K Feb 14, 2023 Common Shares 9.33K $11.96 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Number includes restricted stock units.
F2 Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F3 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.